In light of the announcement made by the company on Thursday, it is likely that the International Isotopes Inc. (OTC: INIS) stock is going to come on to the radars of investors this morning. Yesterday, the company made an announcement about its asset purchase agreement with another entity, and the details could be well worth looking into.
The Update
International Isotopes announced on January 9 that it had completed the amendments and finalized the asset purchase agreement with AMICI Inc. that it had signed on June 16, 2023. In the news release, it was also noted that in order to compensate for the shortfall in assets and inventory the company was going to get as per the provisions of the original agreement, the company would receive other things.
Key Amendments
Those include trademarks, manufacturing molds, device registrations, and production rights to the line of Xenon Systems from AMICI. International Isotopes would also get the intellectual property related to Tru-Fit Mouthpiece and Swirler products.
Further Information
The company further noted in its announcement that the management was glad to have come to the final agreement with regard to the asset purchase agreement. It was further noted that it was a boost for the company to have gotten full control of the intellectual property.
Management Quote
Shahe Bagerdjian, President of INIS, commented, “We’re glad to have come to an agreement with Mr. Bono to finalize the Asset Purchase Agreement. It’s good to now have full control of the intellectual property behind the Swirler® and Tru-Fit™, and we look forward to the Xenon System joining the rest of our RadVent medical device lineup in 2025.”
Fundamentals
| P/E Ratio | -53.2100 |
| PEG Ratio | 0.92 |
| Price to Book | 4.83 |
| Price to Cash Flow | 41.8442 |
| Price to Free Cash Flow | 32.2843 |
| Total Sales (TTM) | 13.14 M |
| Revenue per Share (TTM) | 0.03 |
| Shares Outstanding | 523.553 M |
| Share Float (%) | 143.75 M (27.46%) |
| % Held by Institutions | 0.00 |
